The model's full reasoning — Q2 2023 call → NOWe need answer only yes/no. Need evaluate both gates. Need parse transcript. Gate 1: "is the company talking about how demand is off the charts? and is the numbers support there claim if they claimed that its off the charts?" Need answer yes/no. Transcript: Mike says "we're seeing really unprecedented demand" and "significant demand" and "unprecedented demand" and "massive interest" etc. Numbers support? They mention Mounjaro revenue $960M, paid scripts 67%, access 73%, volume growth 23%, etc. Demand off charts? They say "unprecedented demand" and "supply likely remain tight due to significant demand." So yes. Gate 2: Improvement filter: Determine whether claimed demand strength materially attributable to or amplified by industry-wide scarcity conditions. Indicators: shortages of components/inputs affecting whole industry; capacity allocation; extended lead times; sold out primarily because supply cannot keep up; customers ordering ahead; double-ordering; management defending record orders. Transcript: They discuss supply tight, manufacturing capacity, RTP, vials, pens, "supply will likely remain tight in coming months and quarters due to significant demand." They mention "we're seeing really unprecedented demand" and "tight supply and some spot outages on Mounjaro through end of year." This is supply cannot keep up. But is demand strength attributable to scarcity? They say demand is high, supply tight. The question asks whether claimed demand strength is materially attributable to or amplified by industry-wide scarcity conditions. They mention "industry-wide" scarcity? They talk about their own manufacturing constraints, not necessarily industry-wide. But "shortages of components or inputs affecting whole industry" - they mention "parenteral auto-injector space" constraint, "capacity" and "CMOs" but not necessarily industry-wide. However, they say "unprecedented demand" and "supply likely remain tight" due to demand. The demand is not amplified by scarcity; rather supply is constrained. But the filter asks if demand strength is materially attributable to or amplified by scarcity conditions. They don't mention double-ordering or pull-forward. They say "we're seeing really unprecedented demand" and "massive interest" driven by patient desire. They attribute to fundamental desire. So likely yes, not scarcity-driven.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TRP | TC Energy Corporation | Q1 2024 | 2024-05-03 | B |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C |
| ONON | On Holding AG | Q2 2022 | 2022-08-16 | A |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| ABNB | Airbnb, Inc. | Q1 2022 | 2022-05-03 | A |
| CPAC | Cementos Pacasmayo S.A.A. | Q4 2021 | 2022-02-15 | C |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
ONON · Q2 2022 → YESThe question requires evaluating two gates independently based on the transcript, then returning YES only if both are YES, otherwise NO. Answer with exactly YES or NO. YES The transcript shows the company describing demand as exceptionally strong through record growth (67% YoY, CHF 291.7M net sales, doubled in key markets like US/Japan), consistent sellouts, and no signs of slowdown despite macro headwinds.
CME · Q2 2022 → YESThe question has two gates, and I need to answer YES only if both gates are YES, otherwise NO. And answer with exactly YES or NO. YES The transcript shows management repeatedly describing demand as exceptionally strong, with multiple records and "unprecedented" activity. Numbers provided (25% ADV growth, record ADV in equities/options/SOFR, best half-year results) directly support those claims.
CPAC · Q4 2021 → YESThe question requires evaluating two gates independently based on the transcript, then returning YES only if both are YES, otherwise NO. Answer with exactly YES or NO. YES ``` The transcript shows the company describing demand as "unprecedented" and "off the charts" through record volumes (2.6M tons in 2019 to 3.6M in 2021, ~38-40% growth) and revenue/EBITDA surges (49.